These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9345308)

  • 1. Broad ligand specificity of the transcriptional regulator of the Bacillus subtilis multidrug transporter Bmr.
    Markham PN; LoGuidice J; Neyfakh AA
    Biochem Biophys Res Commun; 1997 Oct; 239(1):269-72. PubMed ID: 9345308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ostensible paradox of multidrug recognition.
    Neyfakh AA
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):151-4. PubMed ID: 11321567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of multiple drugs by a single protein: a trivial solution of an old paradox.
    Vazquez-Laslop N; Zheleznova EE; Markham PN; Brennan RG; Neyfakh AA
    Biochem Soc Trans; 2000; 28(4):517-20. PubMed ID: 10961951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The drug-binding activity of the multidrug-responding transcriptional regulator BmrR resides in its C-terminal domain.
    Markham PN; Ahmed M; Neyfakh AA
    J Bacteriol; 1996 Mar; 178(5):1473-5. PubMed ID: 8631728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates.
    Ahmed M; Borsch CM; Taylor SS; Vázquez-Laslop N; Neyfakh AA
    J Biol Chem; 1994 Nov; 269(45):28506-13. PubMed ID: 7961792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated.
    Ahmed M; Lyass L; Markham PN; Taylor SS; Vázquez-Laslop N; Neyfakh AA
    J Bacteriol; 1995 Jul; 177(14):3904-10. PubMed ID: 7608059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter.
    Zheleznova EE; Markham PN; Neyfakh AA; Brennan RG
    Cell; 1999 Feb; 96(3):353-62. PubMed ID: 10025401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of the multidrug regulator QacR distinguishes residues that are crucial to multidrug binding and induction of qacA transcription.
    Peters KM; Sharbeen G; Theis T; Skurray RA; Brown MH
    Biochemistry; 2009 Oct; 48(41):9794-800. PubMed ID: 19761200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary structural studies on the multi-ligand-binding domain of the transcription activator, BmrR, from Bacillus subtilis.
    Zheleznova EE; Markham PN; Neyfakh AA; Brennan RG
    Protein Sci; 1997 Nov; 6(11):2465-8. PubMed ID: 9385651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of BmrR-drug complexes reveal a rigid multidrug binding pocket and transcription activation through tyrosine expulsion.
    Newberry KJ; Huffman JL; Miller MC; Vazquez-Laslop N; Neyfakh AA; Brennan RG
    J Biol Chem; 2008 Sep; 283(39):26795-804. PubMed ID: 18658145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the transcription activator BmrR bound to DNA and a drug.
    Heldwein EE; Brennan RG
    Nature; 2001 Jan; 409(6818):378-82. PubMed ID: 11201751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of ligand recognition by BmrR, the multidrug-responding transcriptional regulator: mutational analysis of the ligand-binding site.
    Vázquez-Laslop N; Markham PN; Neyfakh AA
    Biochemistry; 1999 Dec; 38(51):16925-31. PubMed ID: 10606527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr.
    Klyachko KA; Schuldiner S; Neyfakh AA
    J Bacteriol; 1997 Apr; 179(7):2189-93. PubMed ID: 9079903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial multidrug efflux: introduction.
    Paulsen IT; Lewis K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):143-4. PubMed ID: 11321565
    [No Abstract]   [Full Text] [Related]  

  • 15. Charge is Major Determinant of Activation of the Ligand-Responsive Multidrug Resistance Gene Regulator, BmrR.
    Bachas S; Kohrs B; Wade H
    ChemMedChem; 2016 May; 11(10):1038-41. PubMed ID: 27010425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prokaryote multidrug efflux proteins of the major facilitator superfamily: amplified expression, purification and characterisation.
    Ward A; Hoyle C; Palmer S; O'Reilly J; Griffith J; Pos M; Morrison S; Poolman B; Gwynne M; Henderson P
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):193-200. PubMed ID: 11321573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of natural substrates and inhibitors of MDR pumps.
    Lewis K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):247-54. PubMed ID: 11321580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal multidrug efflux protein QacA.
    Brown MH; Skurray RA
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):163-70. PubMed ID: 11321569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational plasticity of the coiled-coil domain of BmrR is required for bmr operator binding: the structure of unliganded BmrR.
    Kumaraswami M; Newberry KJ; Brennan RG
    J Mol Biol; 2010 Apr; 398(2):264-75. PubMed ID: 20230832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA.
    Edgar R; Bibi E
    EMBO J; 1999 Feb; 18(4):822-32. PubMed ID: 10022825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.